Investor insights
Sectors invested in
Biotechnology3
Pharmaceutical2
Custom Epigenetic Research Services1
Health Diagnostics1
Real-Time qPCR detection1
Human Infectious diseases Molecular Diagnostics1
Life Science1
Innovating Epigenetics Solutions1
safety pharmacology1
Medical1
cell based assays1
cardiomyocytes1
drug discovery1
Health Care1
iPSC cells1
drug development1
Immunotherapeutics1
Peptides1
Therapeutics1
Autoimmune diseases1
Funding rounds participated in
$9.7M sweet spot round size
Most of their 5 investments are in rounds between $5.7M and $12M
Basic info
Investments made
I
Imcyse SA raised $26M on February 17, 2021
Investors: SRIW, -, SFPI-FPIM, KU Leuven and EPIMEDE
U
Undisclosed raised $9.7M on January 19, 2021
Investors: White Fund SA, SFPI-FPIM and EPIMEDE
U
Undisclosed raised $5.7M on February 11, 2019
Investors: SFPI-FPIM and EPIMEDE
P
Pluriomics raised $12M on November 17, 2017
Investors: -, SRIW, InnovationQuarter, SFPI-FPIM, Vesalius Biocapital and EPIMEDE
D
Diagenode raised $8.5M on June 20, 2016
Investors: -, SRIW, Capricorn Venture Partners and EPIMEDE